This review summarizes the definition and surgical methods of oncometabolic surgery according to previous studies.Then,the authors discuss the beneficial effects observed after gastrectomy in gastric cancer(GC)patient...This review summarizes the definition and surgical methods of oncometabolic surgery according to previous studies.Then,the authors discuss the beneficial effects observed after gastrectomy in gastric cancer(GC)patients with concurrent hypertension or type 2 diabetes mellitus(T2DM).The authors summarize the current studies analyzing the remission rate and the hypotheses of the mechanisms underlying these effects.The remission rate ranged from 42.5%-65.4%in T2DM patients and from 11.1%-57.6%among those with hypertension.Furthermore,the remission of T2DM could have an impact on overall survival rates as well.The mechanisms underlying the remission of hypertension and T2DM is unclear in current studies,but oncometabolic surgery is expected to be applied in clinical practice.In addition,the effect of oncometabolic surgery on other chronic metabolic comorbidities is expected to be proven in further studies.Therefore,the purpose of this review is to discuss the effects of oncometabolic surgery reported in current studies with a primary focus on the remission of hypertension and T2DM after gastrectomy in GC patients.The possibility of the remission of other metabolic comorbidities in GC patients who undergo oncometabolic surgery is also discussed.展开更多
Gastric cancer(GC)remains a substantial health burden worldwide,ranking fifth in incidence and third in mortality among all cancer types.Surgeons have persistently attempted to address this growing burden through surg...Gastric cancer(GC)remains a substantial health burden worldwide,ranking fifth in incidence and third in mortality among all cancer types.Surgeons have persistently attempted to address this growing burden through surgical management of GC encompassing various aspects of surgery,including advances in surgical techniques and tools for minimally invasive surgery,novel technology for real-time image-guided surgery,and function-preserving and oncometabolic surgeries,aimed at improving patients’quality of life.The current perspective discusses the five most critical dimensions of the recent technical improvements and conceptual changes in GC surgery.We recommend further exploration of long-term benefits of these advancements,identification of breakthrough solutions to address current challenges,and delivery of the best quality of care.展开更多
文摘This review summarizes the definition and surgical methods of oncometabolic surgery according to previous studies.Then,the authors discuss the beneficial effects observed after gastrectomy in gastric cancer(GC)patients with concurrent hypertension or type 2 diabetes mellitus(T2DM).The authors summarize the current studies analyzing the remission rate and the hypotheses of the mechanisms underlying these effects.The remission rate ranged from 42.5%-65.4%in T2DM patients and from 11.1%-57.6%among those with hypertension.Furthermore,the remission of T2DM could have an impact on overall survival rates as well.The mechanisms underlying the remission of hypertension and T2DM is unclear in current studies,but oncometabolic surgery is expected to be applied in clinical practice.In addition,the effect of oncometabolic surgery on other chronic metabolic comorbidities is expected to be proven in further studies.Therefore,the purpose of this review is to discuss the effects of oncometabolic surgery reported in current studies with a primary focus on the remission of hypertension and T2DM after gastrectomy in GC patients.The possibility of the remission of other metabolic comorbidities in GC patients who undergo oncometabolic surgery is also discussed.
文摘Gastric cancer(GC)remains a substantial health burden worldwide,ranking fifth in incidence and third in mortality among all cancer types.Surgeons have persistently attempted to address this growing burden through surgical management of GC encompassing various aspects of surgery,including advances in surgical techniques and tools for minimally invasive surgery,novel technology for real-time image-guided surgery,and function-preserving and oncometabolic surgeries,aimed at improving patients’quality of life.The current perspective discusses the five most critical dimensions of the recent technical improvements and conceptual changes in GC surgery.We recommend further exploration of long-term benefits of these advancements,identification of breakthrough solutions to address current challenges,and delivery of the best quality of care.